Abstract
Peritonitis continues to be a complex illness that requires the coordinated efforts of timely surgical intervention, systemic antibiotic therapy, and supportive critical care management. Peritonitis and its accompanying sequela of intraabdominal abscess are frequently associated with activation of the systemic inflammatory response syndrome (SIRS) and is commonly associated with the development of the multiple organ dysfunction syndrome (MODS). Many authors consider peritonitis to be the prototypical infection associated with MODS, although there is general consensus at the present time that any infectious source could potentially activate SIRS and lead to MODS.1 The general perception is that effective intervention in the initial management of patients with peritonitis can avoid subsequent evolution of the multiple organ failure cascade. Some have reported reversal of organ failure with surgical intervention in intraabdominal infection.2–4 This chapter summarizes the significant aspects of the treatment of the complex constellation of diseases called peritonitis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Deutsehman CS, Komstantinides FN, Tsai M, et al: Physiology and metabolism in isolated viral septicemia; further evidence of an organism-independent, host-dependent response, Arch Surg 1987; 122: 21.
Eiseman B, Beart R, Norton L: Multiple organ failure. Surg Gynecol Obstet 1977; 144: 323–326.
Polk HC Jr., Shields CL: Remote organ failure: a valid sign of occult intra-abdominal infection. Surgery 1977; 81: 310–313.
Hinsdale JG, Jaffe BM: Reoperation for intraabdominal sepsis: indications and results in modern critical care setting. Ann Surg 1984; 199: 31–36.
Hoefs JC, Runyon BA: Spontaneous bacterial peritonitis. Dis Mon 1985; 31: 1.
Mosdell DM, Morris DM, Voltura A, et al: Antibiotic treatment for surgical peritonitis. Ann Surg 1991; 214: 543–549.
Autio V: The spread of intraperitoneal infection: studies with roentgen contrast medium. Acta Chir Scand Suppl 1964; 321: 5.
Allen L, Weatherford T: Role of fenestrated basement membrane in lymphatic absorption from the peritoneal cavity. Am J Physiol 1956; 197: 551–554.
Tsilibary EC, Wissig SL: Absorption from the peritoneal cavity: SEM study of the mesothelium covering the peritoneal surface of the muscular portion of the diaphragm. Am J Anat 1977; 149: 127–132.
Polk HG Jr., Miles AA: Enhancement of bacterial infection by ferric iron: kinetics, mechanisms, and surgical significance. Surgery 1971; 70: 71–77.
Pruett TL, Rotstein OD, Fiegel VD, et al: Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. VII. A leukotoxin is produced by Escherichia coli metabolism in hemoglobin. Surgery 1984; 96: 375–383.
Fry DE, Garrison RN, Heitsch RG, et al: Determinants of death in patients with intraabdominal abscess. Surgery 1980; 89: 517–523.
Chetlin SH, Elliott DW: Biliary bacteremia. Arch Surg 1971; 102: 303–307.
Onderdonk AB, Bardett JC, Louie T, et al: Microbial synergy in experimental intraabdominal abscess. Infect Immun 1976; 13: 22–26.
Lorber B, Swenson RM: The bacteriology of intraabdominal infections. Surg Clin North Am 1975; 55: 1349–1358.
Bennion RS, Baron EJ, Thompson Jr. JE, et al: The bacteriology of gangrenous and perforated appendicitis-revisited. Ann Surg 1990; 211: 165.
Christou NV, Turgeon P, Wassef R, et al: Management of intraabdominal infections: the case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. Arch Surg 1996; 131: 1193–1201.
Sheckman P, Onderdonk AB, Bartlett JG: Anaerobes in spontaneous peritonitis. Lancet 1977; 2: 1223.
Donovan AJ, Berne TV, Donovan JA: Perforated duodenal ulcer: an alternative plan. Arch Surg 1998; 133: 1166–1171.
Hurme T, Nylano E: Conservative versus operative treatment of appendicular abscess: experience of 147 consecutive patients. Ann Chir Gynecol 1995; 84: 33–36.
Rodeheaver GT, Pettry D, Thacker JG, et al: Wound cleansing by high pressure irrigation. Surg Gynecol Obstet 1975; 141: 357.
Hudspeth AS: Radical surgical debridement in the treatment of advanced generalized bacterial peritonitis. Arch Surg 1975; 110: 1233–1236.
Polk HC Jr., Fry DE: Radical peritoneal debridement for established peritonitis. Ann Surg 1980; 192: 350–355.
Stone HH, Hooper CA, Millikan WJ Jr.: Abdominal drainage following appendectomy and cholecystectomy. Ann Surg 1978; 187: 606–612.
Atkins RC, Scott DF, Holdsworth SR, et al: Prolonged antibiotic peritoneal lavage in the management of gross generalized peritonitis. Med J Aust 1976; 1: 954.
Stephen M, Loewenthal J: Continuing peritoneal lavage in highrisk peritonitis. Surgery 1979; 85: 604–606.
Uden P, Eskilsson P, Brunes L, et al: A clinical evaluation of postoperative peritoneal lavage in the treatment of perforated appendicitis. Br J Surg 1983; 70: 348–349.
Leiboff AR, Soroff HS: The treatment of generalized peritonitis by closed postoperative peritoneal lavage. Arch Surg 1987; 122: 1005–1010.
Dobrin PB, O’Keefe P, Tatarowicz W, et al: The value of continuous 72-hour peritoneal lavage for peritonitis. Am J Surg 1989; 157: 368–371.
Fry DE, Trachtenburg L, Polk HC Jr.: Serum kinetics of intraperitoneal moxalactam. Arch Surg 1986; 121: 282–284.
Brasel KJ, Borgstrom DC, Weigelt JA: Cost-utility analysis of contaminated appendectomy wounds. J Am Coll Surg 1997; 184: 23–30.
Malangoni MA, Condon RE, Spiegel CA: Treatment of intraadbominal infections is appropriate with single-agent or combination antibiotic therapy. Surgery 1985; 98: 648–655.
Huizinga WK, Baker LW, Kadwa H, et al: Management of severe intra-abdominal sepsis: single agent antibiotic therapy with cefotetan versus combination therapy with ampicillin, gentamicin, and metronidazole. Br J Surg 1988; 75: 1134–1138.
Harding G, Vincelette J, Rachlis A, et al: A preliminary report on the use of ceftizoxime versus clindamycin-tobramycin for the therapy of intraabdominal and pelvic infections. J Antimicrob Chemother 1982; 10(Suppl C): 191–192.
Walker AP, Nichols RL, Wilson RF, et al: Efficacy of a beta-kctam inhibitor combination for icrious intraabdominal infections. Ann Surg 1993; 217: 115–121.
Dougherty SH, Sirinik KR, Schauer PB, et al: Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intraabdominal infection in pediatric and adult patients. Am Surg 1995; 61: 297–303.
Arguedas A, Sifuentes-Osornis J, Loaiza C, et al: An open, multicenter clinical trial of piperacillin/tazobactum in the treatment of pediatric patients with intraabdominal infections. J Chemother 1996; 8: 130–136.
Solomkin JS, Dellinger EP, Christou NV, Busuttil RW: Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intraabdominal infections. Ann Surg 1990; 212: 581–591.
Geroulanos SJ: Meropenem versus imipenem/cilaitatin in intraabdominal infections requiring surgery. J Antimicrob Chemother 1995; 36(Suppl A): 191–205.
Donahue PE, Smith DL, Yellin AE, et al: Trovafloxacin in the treatment of intraabdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Am J Surg 1998; 176(Suppl 6A): 53S–61S.
Barboza E, del Castillo M, Yi A, Gotuzzo E: Clindamycin plus amikacin versus clindamycin plus aztreonam in established intraabdominal infection. Surgery, 1994; 116: 28–35.
Solomkin JS, Reinhardt HH, Dellinger EP, et al: Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intraabdominal infection. Ann Surg 1996; 223: 303–315.
Bohnen JMA, Solomkin JS, Dellinger EP, et al: Guidelines for clinical care: anti-infective agents for intra-abdominal infection. Arch Surg 1992; 127: 83–92.
Anonymous: Prospective, randomized comparison of metronidazole and clindamycin, each with gentamicin for the treatment of serious intra-abdominal infection. Surgery 1983; 93: 221-229.
Niemiec PW, Allo MD, Miller CF: Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care. Arch Surg 1987; 122: 207.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Fry, D.E. (2000). Peritonitis: Management of the Patient with SIRS and MODS. In: Baue, A.E., Faist, E., Fry, D.E. (eds) Multiple Organ Failure. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-1222-5_27
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1222-5_27
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7049-2
Online ISBN: 978-1-4612-1222-5
eBook Packages: Springer Book Archive